Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Dec 19;86(1):96–101. doi: 10.1016/j.ijrobp.2012.11.020

Table 4.

Predictive value of CA19-9 progression after completion of chemoradiation therapy

Outcome Hazard ratio P value
Overall survival 3.65 .001
Progression-free survival 3.04 .001
Freedom from local progression 2.44 .158
Freedom from distant progression 1.75 .206

Abbreviation: CA19-9 = carbohydrate antigen 19-9.

CA19-9 progression was defined as time of first rise of serum CA 19-9 over 90 U/mL.